Professional Documents
Culture Documents
EK-2
$\GQ0PPQRORMLWHULPOHULV|]O(G&HQJL]0VUOJLO$\GQ7SYHGLKHNLPOLLQGHJHQHOYH
LQJLOL]FHNDUO\D]OPWU(VHULoHULVLQGHJHoHQNVDOWPDODUGDV|]ONLoHULVLQGHDoNODQPWU
0-9
5-hydroxytryptamine (5HT) Bkz. Serotonin.
-2 mikroglobulin HLA- PROHNO ]HULQH VRQUDGDQ \DSDQ YH EWQ
LQVDQODUGDRUWDNRODQN'DDUOQGDELUSURWHLQGLU
A
Absorpsiyong]JQYHEHOLUOLELUPDWHU\DOL\DSSHPLSLoLQHDOPD0DNURIDM
GX\DUOROGXXEDkteri hcresini absorbe eder.
ADA $GHQR]LQGHDPLQD]PPQ\HWPH]OLNOHUGHHNVLNOLLELOLQHQELUHQ]LP
ADCC$QWLERG\'HSHQGHQW&HOO&\WRWR[LFLW\$QWLNRUDEDPOVLWRWRNVLVLWH
$GGLVRQ KDVWDO 6UUHQDO EH]LQ RWRLPPQ PHNDQL]PD LOH JHOLHQ ELU
KDVWDOGU
Adezyon 1-<DSPD - PROHNOOHU DUDV JUDYLWDV\RQ LOH PH\GDQD JHOHQ
tutunma
ADK $QWLG]NDVDQWLNRUODU
Adoptif immnite3DVLIEDNON
Adsorpsiyon g]JQ ROPD\DQ ELU PHWDU\DOH \DSDUDN \]H\LQL NDSDWPDN
Boya, srlen herhangi bir yzeye adsorbe olur.
Adjuvan .RQDD YHULOHQ ELU DQWLMHQLQ NRQDN LPPQ VLVWHPL WDUDIQGDQ GDKD
ID]OD LPPXQ FHYDS J|UPHVLQL VDODPDN DPDF\OD DQWLMHQ LoHULVLQH LODYH HGLOHQ
NLP\DVDO PDGGH *HQHOOLNOH DOXPLQ\XP MHO ODQROLQ YH SDUDILQ JLEL\DODULoHULVLQGHNL
VX HPOVL\RQu veya benzeri maddelerdir tam olmayan FreundV DGMXYDQ LVPLQL DOU
oHULVLQH|OMycobacterium smegmatis hcreleri ilave edilirse tam FreundVDGMXYDQ
LVPLQLDOU
Afinite 0ROHNOOHU DUDV oHNLP LNL NLP\DVDO PDGGHQLQ ELUELUOHULQH NLP\DVDO
isteklilikleULg]JODQWLNRUODUQDQWLMHQHDILQLWHVL\NVHNWLU
Afinite matrasyonu%LUDQWLMHQOH|QFHGHQNDUODDQEHOOHNKFUHOHULQLQD\Q
DQWLMHQ LOH \HQLGHQ NDUODWQGD GDKD \NVHN DILQLWHVL ROPDV YH GDKD NXYYHWOL
cevap vermesi.
1194
Antikor%LUDQWLMHQHNDUUHWLOHQYHRQXQODUHNDVL\RQDJLUHELOHQJOXNRSURWHLQ
$QWLNRUID]ODV $QWLMHQ|]JODQWLNRULOHELUHELUHOHQGLLQGHVD\FDDQWLNRUXQ
ID]ODJHOPHVLGXUXPX/DWWLFHKLSRWH]LQHJ|UHSUHVLSLWDV\RQVUDVQGDDQWLNRUID]OD
ROGXXQGDDQWLMHQPROHNOQQEWQGHWHUPLQDQWODUDQWLNRUWDUDIQGDQLJDOHGLOLUYH
presipitasyon engellenir. Agltinasyon testinde ise antikoUID]ODVSUR]RQROXPDVQD
sebep olur.
Antikor varyasyonu $\QLDQWLMHQH|]JORODQEWQDQWLNRUODUD\QPROHNOHU
\DSGD ROPD]ODU ]RWLSLN YDU\DVD\RQ $\Q WUQ VDGHFH R ELUH\LQH DLW IDUNOONODU
RODELOLU %XQODU DQWLNRUX ROXWXUDQ P51$ LQWURQODUQGDNL IDUNOONWDQ ND\QDNODQU
$OORMHQLNYDU\DV\RQ$QWLNRUXQWUH|]HOIDUNOODPDVGU.|SHNWHNLYHLQVDQGDNLDQWL-
KHPRILOXVDQWLNRUODUQJHQHOOLNOHDU]LQFLUOHULIDUNOGUG\RWLSLNYDU\DV\RQ
Antiserum %DN VHUXP %HOLUOL ELU DQWLMHQH NDU ROXPX KD]U DQWLNRU
bulunduran serum.
AP-1 Aktive edici protein PPXQDNWLYDV\RQXEDODWDQELUOHQIRNLQ
APC (ASH,Antigen Presenting Cells) Antijeni kompetan hcrelere sunan
hcrelerdir: makrofajlar, folikler dentritik hcreler, langerhans hcrelHUL SDUPDNV
LQWHUGLJLWDWLQJ IROLNOHU KFUHOHU 'L SXOSDV LoHULVLQGH RGRQWREODVWODU SXOSD
PDNURIDMODU
APP$FXWH3KDVH3URWHLQ,VRNSURWHLQL
Asidofil6LWRSOD]PDVDVLWER\DODULOHER\DQDQO|NRVLW
ASO (AntiStreptolizin-O testi) Streptokoklar streptolizin-O isimli bir hemolizin
retirler. Serumda streptolizin-2\D NDU ROXDQ ,J* DQWLNRUODUD $62 GHQLU 1RUPDO
GHHULQLWHGLU
Antitoksin 9HULOHQ ELU WRNVLQH NDU ROXDQ DQWLNRUODU %X WHULP D\UFD EX
DQWLWRNVLQLQEXOXQGXXVHUXPXLIDGHHWPHNLoLQGHNXOODQOU
Apoptoz3URJUDPODQPKFUH|OP
Arthus reaksiyonu7LS,,,DUGX\DUOON%XWHULPDVOQGDDQWLNRUID]ODVLOH
seyreden deneysel bir vaskliti tarif eder. Serumunda fazla miktarda zgl antikor
EXOXQDQ ELU KD\YDQD D\Q DQWLMHQ GHUL DOWQGDQ YHULOGLLQGH ROXDQ DQWLMHQ-antikor
kompleksleri damar eperinde harabiyete sebep olur.
ASH Antijen sunan hcre, Bkz. APC.
Asthma$VWPKDVWDO
$ 9HULOGLL NRQDN RUJDQL]PDGD NHQGLVLQH |]JODQWLNRU\DSPQLQGNOH\HQ
antijenik materyal.
Atopi$UGX\DUOONJHOLWLUPH\HPHLOOLROPDGXUXPX
Atenasyon DWHQH HWPHN %LU PLNURRUJDQL]PDQQ YLUXODQVQ D]DOWPDN %X
genellikle 2 yol ile olur, 1) kaynatarak veya 2) formalin ierisinde bekleterek.
$WHQHD &DQODPDYLUXODQVD]DOWOPPLNURRUJDQL]PDODUQNXOODQOGD
Bkz. Atenasyon.
Avidite Antijen-antikor kompleksinin satbilitesi
Avustralya antijeni Bkz. HBsAg
B
B lenfositi %LUOHQIRVLWFLQVLGLU%XUVDIDEULFXVWDJHOLHQOHQIRVLWDQODPQWDU
%XNHOLPHQLQEDQGDNL%KDUILND\QDQ%XUVDIDEULFXVNHOLPHVLQGHQDOU$QFDNEX
GRNX VDGHFH NXODUGD EXOXQXU PHPHOLOHUGHNL NDUO NHPLN LOLLGLU 'ROD\V\OD %
OHQIRVLWL NHPLN LOLL YH NDUDFLHUGH UHWLOHQ OHQIRVLW GHPHNWLU 6YVDO EDNONWDQ
sorumludur yzeylerinde IgM ve IgD bulunur.
1196
C-
C reaktif protein (CRP) %D]LQIODPDWXYDUURPDWL]PDODWHJLELKDVWDONODUGD
LPPXQVLVWHPWDUDIQGDQROXWXUXODQELUSURWHLQGLU<HWHULQFH|]JOGHLOGLU%LOKDVVD
Streptococcus pneumonia ve Aspergillus \HOHULQLQ VHOOHU HNVWUDNWODU LOH UHDNVL\RQ
verir.
cAMP Siklik adenozin monofosfat.
Carcinoma in situ Bu WHULPNDQVHULQSUHLQYD]LIRODQHUNHQG|QHPLQLDQODWU
CD&OXVWHURIGLIIHUDQWLDWLRQ+FUHVHULOHULQLQIDUNOODPDV
CEA Karyo embriyojenik antijen.
CGRP (Calcitonin Gene Related Peptide) Nrojenik inflamasyon mediyatr
RODUDNGLSXOSDVVLQLUOLIOHULQGHQVDOQDQELUQ|URSHSWLW
Chediak-Higashi Sendromu RWR]RPDO UHVHVLI JHoLOL SL\RMHQ EDNWHUL
LQIHNVL\RQODUQQ VN J|UOG DOELQL]PLQ HOLN HWWLL ELU LPPQ \HWPH]OLN
sendromudur.
Chimera%LUFDQOGDLNLIDUNOJHQHWLN\DS\DVDKLSKFUHOHULQEXOXQPDV
Chushing sendromu Srrenal bezin hiperfonksiyonu ile olan endokrin
KDVWDON
CL &RQVWDQW /LJKW FKDLQ $QWLNRU LPPXQ JOREXOLQ \DSVQGD EXOXQDQ YH
DQWLNRUGDQDQWLNRUDGHLLNOLNOHUJ|VWHUPH\HQKDILI]LQFLUE|OJHVL
CMIS (Common Mucosal System)
CMV Sitomegalovirus.
Con A Concanavalin A.
Coombs serumu Anti-insan Ig serumu.
Coombs testi NL WUO \DSOU 'LUHNW PHWRW <HQLGRDQGD 5K KDVWDO
SKHVL LOH NRUGRQGDQ VLWUDWO NDQ DOQS GHID VHUXP IL]\RORMLN LOH \NDQU ]HULQH
&RRPGVVHUXPXGDPODWOU$JOWLQDV\RQYDUVDVRQXoROXPOXGXUQGLUHNWPHWRW5K
KDVWDO SKHVL LOH DQQHGH DQWL5K DQWLNRUODU DUDPDN LoLQGLU *HEH DQQHQLQ
serumuna ORh eritrosit sspansiyonu eklenir. Agltinasyon varsa sonu olumludur.
CPF (Clot Promoting Factor) Mast hcrelHULQGHQVDOQDQYHSKWROXWXUDQELU
faktr.
CRF Coagulase Reacting Factor.
Cryoglobulin6RXNDJOWLQDV\RQYHUHQVHUXPJOREXOLQOHUL
CS Sirkumsporozoit.
CTL (Cytolytic T lymphocyte) Sitolitik T lenfosit.
1197
D
DALT 'XFW$VVRFLDWHG/\PSKRLG7LVVXHVDOJEH]LNDQDOODU ile ilgili lenfoid
doku.
Danysz fenomeni (LW PLNWDUGD WRNVLQ DQWLWLRNVLQ NDUPQ QDVO
NDUWUOGQD EDO RODUDN WRNVLN RODELOHFHLQL LIDGH HGHU (HU HLW PLNWDUGD WRNVLQ
DQWLWRNVLQ LoHULVLQH KHSVL ELU DQGD G|NOUVH NDUP QRQWRNVLNWLU <DUV ilave edilip
GDNVRQUDGLHU\DUVLODYHHGLOLUVHNDUPWRNVLNWLU
DAT (Differantial Agglutination Test).
DAF 'HFD\$FFHOHUDWLQJ)DFWRU<NPK]ODQGUDQIDNW|U
DAG Diasilgliserol.
Degranlasyon*UDQOOHULQDoODUDNRUWDPDVHUEHVWOHPHOHUL
De novo$\QNLP\DVDOPDGGHQLQNRQDNWDWHNUDUVHQWH]OHQPHVL
Denatrasyon'RDONLP\DVDO\DSVQND\EHWPHVL*HULG|QPV]GU
Dentritik$DoGDOEHQ]HULJ|UQPGHRODQGDOODQSEXGDNODQDQ
Desensitizasyon'X\DUV]ODWUPDN
Determinant $\UHGLFLSDUoD
DIC 'LVVHPLQH,QWUDYDVFXODU&RDJXODWLRQ<D\JQGDPDULoLSKWODPD
Di George Sendromu Konjenital timus hipoplazisi veya agenezisi sebebiyle,
7 OHQIRVLWOHU D]DOP YH\D \RNWXU 3HULIHUGHNL OHQIRVLWOHULQ oRX YH\D WDPDP %
lenfositleridir. Mikobakteri, maQWDU YH YLUXV LQIHNVL\RQODUQD GX\DUOGU (N RODUDN
paratiroid bezi de bulunmayabilir.
Diseminasyon<D\OPD
Disemine<D\JQ
Displazi+FUHOHULQG]HQVL]DPDQHRSODVWLNROPD\DQoRDOPDODU
DNCB Dinitrochlorobenzene.
DNP Dinitrofenol.
'RDODQWLNRU Plazmada bulunan immunoglobulinler.
Domain ilmik.
DOS'LHWL2OXX6YV
Duffy antijeni (ULWURVLW KFUH PHPEUDQQGD EXOXQDQ ELU WU PLQ|U NDQ JUXEX
antijeni.
E
1198
F
Fab para $QWLJHQ %LQGLQJ )UDJPHQW $QWLNRUPROHNOQQPPXQJOREXOLQ
DQWLMHQLWXWDQSDUoDV
FACS Florescent Activated Cell Sorter.
Fc para (Cristalizable Fragment) Antikor moleklnQPPXQJOREXOLQNRQDN
VDYXQPDHOHPDQODUWDUDIQGDQWDQQDQSDUoDV
FITC Floresin izotiyosiyanat.
Fitohemagltinin Lektin. Mitozu indkler ve lenfositlerin transformasyonunu
VDODU
Forshay testi Franciella tularenisH NDU JHFLNPL DU GX\DUOO Dnlamak
LoLQ\DSODQYHWEHUNOLQWHVWLQHEHQ]H\HQELUWHVW
Forssman antijeni Streptococcus pneumoniada, at, koyun ve kpek
HULWURVLWOHULQLQ \]H\LQGH GRPX]XQ ED] GRNXODUQGD EXOXQDQ ELU JXUXS KHWHURILO
antijene bu isim verilir. Forssaman antijeni tavDQGD EXOXQPD] %X VHEHSOH DQWL-
)RUVVPDQDQWLNRUODUWDYDQGDKD]UODQU
FR Framework blgesi.
Freunds adjuvan $QWLMHQ YHULOHQ ELU NRQDQ LPPXQ FHYDEQ DUWUPDN LoLQ
DQWLMHQH LODYH HGLOHQ NDWN PDGGHOHUL %DVLWoH \D HPOVL\RQX NXOODQOUVD WDP
olmayan )UHXQGV DGMXYDQ GHQLU (HU LoHULVLQH |O Mycobacterium smegmatis
KFUHOHULLODYHHGLOLUVHWDP)UHXQGVDGMXYDQDGQDOU
G
G6PD Glukoz-6-fosfat dehidrogenaz.
GALT *XW $VVRFLDWHG /\PSKRLG 7LVVXHV %DUVDQ OHQIRLG GRNXODU 3H\HU
SODNODUYV
Gamma globulin 6HUXPGDEXOXQDQJOREXOLQOHULQELUVQI
GCSF Granloist koloni stimule eden faktr.
GM-CSF Granlosit-makrofaj koloni stimule eden faktr.
GTA *HoWLSDUGX\DUOONWLS
GTP Guanozin trifosfat.
GVH (Graft versus Host) Graft reddi reaksiyonu.
1199
H
Hapten .HQGLVL DQWLNRU ROXWXUPD\DQ QRQLPPXQRMHQ DPD PHYFXW
DQWLNRUODUOD |]JO RODUDN ELUOHHQ VDI SROLVDNNDULW YH\D OLSLW PROHNOOHUGLU %LU WD\F
SURWHLQLOHELUOHLUVHDQWLMHQ|]HOOLNND]DQU%LURUJDQL]PDLoLQKDSWHQRODQELUPDGGH
diHU ELU RUJDQL]PD LoLQ DQWLMHQLN RODELOLU gUQHLQ Streptococcus pneumoniaQQ
NDSVOSROLVDNNULWOHULWDYDQLoLQKDSWHQLQVDQLoLQDQWLMHQGLU
HAT Hipoksantin-aminopterin-timidin.
HBIG Hepatit B Ig.
HbsAg (Hepatitis B Surface Antigen, Avustralya antijeni) Hepatit B virusunun
yzey antijeni.
HBV Hepatit B virus.
HCG Human chronic gonadotropin.
Heterotransplantasyon Bkz. Transplantasyon.
HEV +HSDWLW ( YLUXV +LJK (QGRWHOLDO 9HQXOHV /HQI GPOHULQLQ
PHGXOODVQQ KHPHQ GQGD SDUDNRUWLNDO E|OJHGH HQGRWHO WDEDNDV NDOQODDUDN
|]HOOHPLOHQIGDPDUODU
Heterofil antijen %LUELUOHUL\OH JHQHWLN RODUDN KLo DODNDV ROPD\DQ DW NX
NHPLUJHQJLELFDQOODUQGRNXODUQGDEXOXQDQDQWLMHQLN\DSODUQPROHNOHUPLPDULOHUL
tesadfen birbirine benziyor olabilir. Byle antijenlere heterofil antijen denir.
Heteroimmunizasyon %DND ELU FDQOQQ ELU ELUH\LQLQ RUJDQ GRNX YH\D
DQWLMHQOHULQHNDUELUEDNDFDQO\EDNODPDN
HLA +XPDQ OHXFRF\WH $QWLJHQ QVDQ O|NRVLW \]H\LQGH EXOXQDQ
endoantijenler. Doku uygunluk antijenidir. Immun hcreler kendisinden olan veya
ROPD\DQKFUHOHULEXQDEDNDUDNWDQU
HLA-1 %X DQWLMHQOHU ELUH\LQ EWQ oHNLUGHNOL KFUHOHULQLQ PHPEUDQQGD
bulunur. CD8 7 OHQIRVLWOHUL WDUDIQGDQ WDQQU YH EDODQG KFUHQLQ OL]LVLQH VHEHS
olur.
HLA-2 B lenfositleri, makrofaj, dentritik hcre, endotel hcreleri ve aktive T
OHQIRVLWOHULQGH EXOXQXU 0DNURIDM YH OHQIRVLW HWNLOHLPLQGH URO DOU &' 7 OHQIRVLWOHUL
WDUDIQGDQWDQQU
Homotransplantasyon Bkz. Transplantasyon.
HSA+XPDQ6HUXP$OEXPLQQVDQVerum albmini.
Hiperimmun serum Yksek titrede zgl antikor ieren serum.
HRF Homolog Restriction Factor.
HSV Herpes Simplex Virus.
HTLV-1 Human T lymphothropic Virus-1
Humoral immunite 6YVDO EDNON $QWLNRUODUQ YH D\UFD NRPSOHPDQ
interferon, li]R]LPSURSHUGLQLoHUHQYFXWVYODUQQUROR\QDGEDNON
+FUH\HEDOLPPXQLWH7LS,9DUGX\DUOONDQWLNRUEDPOROPD\DQDU
GX\DUOON7KFUHOHULQHEDODUGX\DUOONUHDNVL\RQODUQLIDGHHGHU
I
ICAM (Intercelullar adhesion PROHFXOH+FUHOHUDUDVWXWXQPDPDWHU\DOL
IDDM ,QVXOLQ 'HSHQGHQW 'LDEHWHV 0HOOLWXV ,QVOLQ NXOODQPD\ JHUHNWLUHQ
diyabet.
IEL (IntraEpitelial lymphocyt) Epitel doku ierisinde yer alan lenfositler.
1200
K
Kanserojen Bkz. Onkojenik
Karsinojen Bkz. Onkojenik
KGH Kronik graQORPDW|]KDVWDONODU
KKK .]DPN-.]DPNoN-Kabakulak.
Klasik aktivasyon .RPSOHPDQQ &T SDUoDVQQ DQWLNRUXQ )F SDUoDVQD
EDODQPDVLOHEDOD\DQNRPSOHPDQUHDNVL\RQX
Kompetan hcre Kendisine antijen sunulan, belirli bir fonksiyon iin
|]HOOHPLLPPn hcre.
Kompleman7D]HVHUXPGDYHGRNXVYODUQGDEXOXQDQYHDNWLYHHGLOGLLQGH
]LQFLUOHPHUHDNVL\RQODUDJLUHUHNDQWLMHQLN\DS\DLPPXQFHYDSROXWXUDQFLYDUQGD
UHDNWLISURWHLQGHQROXDQVLVWHP
Kompleman aktivasyonu Herhangi bir antijen veya antijen-antikor kompleksi
WDUDIQGDQ NRPSOHPDQQ &T SDUoDVQGDQ LWLEDUHQ ]LQFLUOHPH UHDNVL\RQODUQQ
EDODWOPDV%XROD\&D2+ ve Mg2+L\RQODUJHUHNVLQLU6UD\ODYH
SURWHLQOHUL DNWLYH ROXU %XQD NODVLN \RO GHQLU %LU EDND \RO $OWHUQDtif yoldur
DNWLYDV\RQQFNRPSOHPDQSURWHLQLQGHQEDODU
Kompleman fiksasyon testi 9HULOHQ ELU |UQHNWH NRPSOHPDQ DNWLYH
HGHELOHFHN KHUKDQJL ELU DQWLMHQLN GHWHUPLQDQW EXOXQXS EXOXQPDGQ DQODPDN LoLQ
X\JXODQU
Kopresipitasyon Normalde presipite edilemeyen molekllerin veya
komplekslerin presipitasyonu
Kriptik anijen (sessiz determinant) Bir antijen moleklnde antijenik
GHWUPLQDQWLoHULENOHUHNNDWODQDELOLUYHLPPXQKFUHOHULQWHPDVQGDQX]DNRODELOLU
%|\OHGXUXPODUGDNXYYHWOLDQWLMHQROPDVQDUDPen bu molekl sessizce kalabilir.
L
LAK /\PSKRNLQH$FWLYDWHG.LOOHU/HQIRVLWX\DUV\OD|OGUFRODELOHQKFUH
/DSLQL]H D /DSLQL]HG YDFFLQH 9LUXODQV oRN VD\GD VHUL SDVDMODU LOH
D]DOWOPFDQOD$WHQHD
LBP Lipopolisakkarit Binding Protein.
Lenfokin 6DOJODQDUDN OHQIRVLWOHU DUDV KDEHUOHPH VDOD\DQ NLP\DVDO
maddeler.
LCM Lenfositik koriyomenenjit.
LF Limes floklasyonu.
LFA Leucocyte Function Associated.
LGL (arge Granular Lymphocyte). ok ekirdekli lenfositler.
LPS Lipopolisakkrit.
LTB4 Lkotrien B4.
LT Lenfotoksin.
M
Maloney Testi'LIWHULWRNVRLGLQHDUGX\DUOOQWHVSLWHGLOGLLELUGHULWHVWL
1202
N
NALT (Nasopharyngeal Associated Lymphoid Tissue) Nazofarinks ile ilgili
lenfoid doku.
NBT Nitroblu tetrazolinyum test.
NCF Ntrofil kemotaktik faktr.
NK Natrel killer hcresi.
NO Azot monoksit, nitrik oksit.
NOD Non-obese diyabetik .
1203
Ntralizasyon NL DQODPD JHOHELOLU %LU o|]HOWLQLQ DVLWLQ ]HULQH DONDOL Yeya
bir alkalinin zerine asit ilave ederek zeltinin asitlik veya alkalilik derecesini
D]DOWPDN WDPSRQODPDN %LU NLP\DVDO PROHNOQ DQWLMHQLN |]HOOLLQL RUWDGDQ
NDOGUDFDNHNLOGH|]JODQWLNRUODULOHELUOHWLUPH\LHVDVDODQLPPQRORMLNELUWHVW
Ntralizasyon testi $QWLMHQOHULQ |]JO DQWLNRUODU LOH EDODQDUDN Q|WUDOL]H
HGLOGLLELUWHVW
Ntrofil6LWRSOD]PDVQ|WUDOER\DODULOHER\DQDQO|NRVLW
Ntropeni'RODPGDNLNDQGDQ|WURILOO|NRVLWOHULQD]DOPDV
Null hcreleri Ne B ne de T cinsi lenfositler.
O
OAF Osteoclast Activating Factor. Bir lenfokindir.
OKVH 2WRLPPQNROODMHQYDVNOHUKDVWDON
Onkofetal antijen IHWDO DQWLMHQ )HWDO KD\DWWD EXOXQDQ DPD HULNLQGH KLo
EXOXQPD\DQ YH\D oRN D] EXOXQDELOHQ DQWLMHQOHUGLU %D] NDQVHUOHUGH \HWLNLQGH
kandDNLPLNWDUODUDUWJ|VWHULU'L\DJQRVWLNDPDoODUODWHVSLWHGLOLU
OnkojenikNDQVHURMHQNDUVLQRMHQ.DQVHUROXPDVQDVHEHSRODQ
Ontogeni RQWRJHQ\/HQIRLGKFUHOHULQELUH\VHOJHOLPHVL
Opsonin %DNWHULOHULQ IDJRVLWLN KFUHOHU WDUDIQGDQ GDKD NROD\ WDQQPDVQ
VDOD\DQDQWLNRUQLWHOLLQGHNLNRPSOHPDQSURWHLQOHUL
Opsonizasyon .RPSOHPDQQ EDODQG LoLQ NROD\ YH K]O JHOLHQ IDJRVLWR]
ROD\
Optiumum %HNOHQHQ XPXODQ PLNWDUGD ID]OD YH\D D] GHLO QRUPDO NRXO YH
normal miktarda olan.
OPV Oral poliovaksin.
Otoagltinasyon %HNOHGLNoHNHQGLOLLQGHQRUWD\DoNDQDJOWLQDV\RQ
Otoantikor .HQGLDQWLMHQLQHNDURODDQDQWLNRU
Otoantijen .RQDQNHQGLVLQHDLWDQWLMHQ
2WRLPPQKDVWDON.RQDQNHQGLKFUHOHULQHNDULPPQFHYDSEDODWPDV
LOHROXDQ\D\JQGRNXKDUDEL\HWLLOHVH\UHGHQQRQLQIHNVL\|]KDVWDONODU
Otograft 2WRWUDQVSODQWDV\RQ DPDF LOH D\Q ELUH\LQ EDND ELU E|OJHVLQGHQ
DOQDQGRNX
Otokrin etki %LU LPPQ KFUHGHQ VDOJODQDQ VLWRNLQOHULQ \LQH D\Q KFUH\L
etkilemesi.
Otolog .LLQLQNHQGLGRNXODUQGDQUHWLOHQ
Ototransplantasyon Bkz. Transplantasyon.
P
PAF 3ODWHOOHW DNWLYH HGLFL IDNW|U 0HPHOL KFUHOHULQLQ PHPEUDQQD EDO
fosfolipaz-A2DUDFOLOHVDOJODQDQELUHQ]LPGLU
PALS Periarteryel lenfoid (manto) doku. Dalaktaki ana arteri epeevre
NXDWDQDNSXOSDGRNXVX
Pandemi %LU LQIHNVL\RQ KDVWOQQ ELU NWD YH\D ELU NDo ONHGH D\Q DQGD
\D\JQHNLOGHRUWD\DoNPDVGU
Parakoaglasyonh]HULQHSOD]PDHNOHQLQFHROXDQNRDJODV\RQ
Parakrin etkiPPQKLFUHGHQVDOQDVLWRNLQOHULQVLVWHPLNGRODPDNDWOPD\S
VDGHFHEXOXQGXXE|OJHGHNLORNDOHWNLVL
1204
Q
Quellung reaksiyonu .DSVOLPHUHDNVL\RQX
R
1205
S
Sabin-Feldman Testi 7RNVRSOD]PRVLV WDQVQGD NXOODQODQ ELU WHVWWLU )DUH
SHULWRQXQGD UHWLOHQ WRNVRSOD]PDODUQ KDVWD VHUXPXQGD FDQOONODUQ NRUXPDV
HVDVQDGD\DQU
SALT (Skin Associated Lymphoid Tissue). Deri ile ilgili lenfoid doku.
Self tolerans .RQDQ NHQGL DQWLMHQOHULQH NDU LPPQ \DQW ROXWXUPDPDV
halini ifade eder.
Serpin Serin proteaz inhibitr.
Seroloji $QWLMHQOHU DQWLNRUODU YH DUDODUQGDNL HWNLOHLPOHU ]HULQH
ODERUDWXYDUGD\DSODQoDOPD
Serotip $\Q EDNWHULQLQ IDUNO \]H\ DQWLMHQOHULQH VDKLS ROGXX LoLQ VHURORMLN
RODUDNIDUNO|]HOOLNJ|VWHUHQWLSL
Serotonin +70DVWKFUHOHULYHWURPERVLWOHUWDUDIQGDQVDOQDQYHWULSWRIDQ
(bir amiQR DVLWQ GHNDUERNVLODV\RQXQGDQ DoD oNDQ PDGGH $QDILODNVL\H NDWOU
histamine benzer etki gsterir.
Serum .DQQVYNVPGUoHULVLQGHHOHNWUROLWDOEXPLQOHUILEULQRMHQEXOXQXU
Plazmada bunlar bulunmaz.
1206
T
7 EDPV]- %X HN |QQH JHOGLL LIDGH\H 7 OHQIRVLWOHULQGHQ EDPV] ROGXX
DQODPQ YHULU 7 OHQIRVLWOHULQLQ YDUONODU JHUHNPHGHQ KD]UODQDQ DQWLNRU YH\D 7
OHQIRVLWOHULQLQ PGDKDOH HWPHGLL DQWLMHQOHU YH\D 7 OHQIRVLWOHULQLQ NDUPDG
EDNONLoLQNXOODQOU
T lenfositi %LUOHQIRVLWFLQVLGLU7LPXVWDUHWLOGLLLoLQEDQD7KDUILJHOLU
TCR-1 T lenfositlerinin %5 inin yzeyinde bulunan heterodimer polipeptit
\DSGD ELU UHVHSW|UGU 9X PDGGHQLQ ROJXQODPDP 7&5- ROGXX
zannedilmektedir.
TCR-2 T lenfositlerinin %95 inin yzeyinde bulunan 90kDa luk bir polipeptit
reseptrdr.
Tegment NL DQODPGD NXOODQOU 7P YFXW GHULVL %LU ROXXPX GWDQ
saran tabaka (kapsl, kabuk, zar vs..)
Tetanospazmin ClostridiumODUQVDOGQ|URWRNVLQ\DSVQGDELUHQ]LP
TGF-.7UDQVIRUPLQJ*URWK)DFWRU.7UDQVIRUPHHGLFLEyme faktr.
1207
U
Urtiker.DQW
V
VEGF Vaskler endotelyal byme faktr.
VDRL test 9HQHUHDO 'LVHDVHV 5HVHDUFK /DERUDWRU\ 7HVW 6ILOL]LQ WDQVQGD
NXOODQODQ LQDNWLYH KDVWD VHUXPX ]HULQH NDUGL\ROLSLQ-lesitin-kolesterol ilavesi ile
\DSODQVHURORjik bir test.
Vi antijeni Salmonella typhi ve Salmonella paratyphi C, Citrobacter YH ED]
atipik Escherichia coli WUOHULQGH EXOXQDELOHQ SROLVDNNDULW ELU DQWLMHQGLU <DSV 1-
acetylgalactosaminuronic acidtir. Termolabildir. Somatik O antijenini maskelemesini
HQJHOOHPHNDPDF\ODVWOUVDWDKULSROXU
VIP 9DVRDFWLYH ,QWHVWLQDO 3RO\SHSWLGH 'L SXOSDVQGD Q|URMHQLN LQIODPDV\RQ
PHGL\DW|URODUDNVLQLUOLIOHULQGHQVDOQDQELUQ|URSHSWLW
VL 9DULDEOH /LJKW FKDLQ $QWLNRU LPPXQ JOREXOLQ \DSVQGD EXOXQDQ ve
DQWLNRUGDQDQWLNRUDGHLLNOLNOHUJ|VWHUHQKDILI]LQFLUE|OJHVL
VLA (Very Late Activator) Adezyon yapan, integrin grubu 6 tane proteindir.
VLA-4 ve VLA-ELUHUILEURQHNWLQOLJDQWGU9/$-ODPLQLQOLJDQWGU
1208
W
Wassermann reaksiyonu 6ILOL] WDQVQGD NXOODQODQ YH :DVVHUPDQQ
DQWLNRUODUQQWHVSLWLQLKHGHIOH\HQVHURORMLNELUWHVW
Widal testi SalmonellaODUD |]JO VHUXP DQWLNRUODUQ WHVSLW HGHQ ELU
agltinasyon testi.
Wiskott-Aldrich Sendromu ; NURPR]RPXQD EDO UHVHVLI JHoLOL % YH 7
lenfosit disfonkVL\RQKDVWDOGU%|\OHKDVWDODUGD&'VHQWH]OHQHPH]
X
X hcreleri $QWLMHQLOHKHQ]KLoWHPDVHWPHPLNRPSHWDQOHQIRVLWOHU
Y
Y hcreleri $QWLMHQ LOH LON WHPDVQ VDODP NRPSHWDQ OHQIRVLWOHU 0HPRU\
KFUHOHU+DI]DKFUHOHULELUHU<KFUHVLGLU
Z
Z hcreleri PPXQHIHNW|UKFUHOHU
Zara hcum kompleksi .RPSOHPDQ UHDNVL\RQXQXQ VRQXFX RODUDN \DEDQF
KFUH PHPEUDQQD EDODQDUDN KLGURILOLN |]HOOLL\OH ]DUQ LoLQH JLUHQ ELU WHN &-8
SDUoDV NRPSOHPDQ - WDQH & SDUoDVQ ]HULQH oHNHU 0RQRPHULN SUoteinler
RODQ & ODU oHSHoHYUH ]DUD \DSDUDN - $QJVWU|P oDSQGD GHOLN DoDUODU &
SDUoDV]DUDKFXPNRPSOHNVLDGQDOU
Zimojen (Zymogen) Kompleman aktivasyonunda bir sonraki kompleman
proteinini uyaran her bir paraya zimojen denir.
KAYNAK:
Singleton P, Sainsbury D. Dictionatry of Microbiology. NewYork, Johns WileySons,1978.
*OPH]ROX((UJYHQ6PPQRORML$QNDUD+DFHWWHSH7D\D\QODU
7HHNNU6|]OQKD]UODQPDVQDHPHLJHoHQ'U'HYULP6(d17\HWHHNNUOHU